Kayla Bargo
Family · Barbourville, KYNPI 1730782699
Payments from drug & device makers
Across 102 payments — averaging $15.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$362
- Bayer$273
- Phathom Pharmaceuticals, Inc.$169
- Lilly USA, LLC$128
- Averitas Pharma Inc.$127
- Novo Nordisk$90
- plus $424 from 11 others
What the payments were for
- Food & beverage$1,573100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $362 |
| Bayer | 14 | $273 |
| Phathom Pharmaceuticals, Inc. | 14 | $169 |
| Lilly USA, LLC | 8 | $128 |
| Averitas Pharma Inc. | 7 | $127 |
| Novo Nordisk | 6 | $90 |
| Madrigal Pharmaceuticals | 5 | $82 |
| Ardelyx, Inc. | 4 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $74 |
| Regeneron Healthcare Solutions, Inc. | 3 | $65 |
| Exact Sciences | 2 | $28 |
| QOL Medical, LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
How this compares
$1,573 in reported general payments places this provider in the 70th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 23 | $21,456 |
| MounjaroTirzepatide | 12 | $11,699 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $9,669 |
| SymbicortBudesonide/Formoterol Fumarate | 19 | $4,457 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 51 | $1,264 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $891 |
| Nortriptyline Hcl | 12 | $667 |
| Cilostazol | 16 | $636 |
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 11 | $626 |
| Gabapentin | 67 | $577 |
| Fluticasone Propionate | 17 | $488 |
| Omeprazole | 61 | $486 |
| Levothyroxine Sodium | 44 | $453 |
| Atorvastatin Calcium | 61 | $448 |
| Hydroxyzine Hcl | 24 | $351 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $128 | $11,69912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,374 family providers in Kentucky.
Other family in Barbourville
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.